Nested variant of urothelial carcinoma complicated with pulmonary lymphangitis carcinomatosis. Case report
Main Article Content
Keywords
Urinary Bladder Neoplasms, Nested Variant of Urothelial Carcinoma, Pulmonary Lymphangitis Carcinomatosis
Abstract
Abstract
Background: Nested variant of urothelial carcinoma is a rare entity characterized by a particularly aggressive clinical course and a poor prognosis. Although disease progression can involve the lung parenchyma, pulmonary carcinomatous lymphangitis is an exceptionally rare manifestation. Up until the date of this publication, evidence in literature is limited, highlighting the rarity of this pattern of dissemination and the importance of its timely recognition.
Clinical case: A 72-year-old man with initial macroscopic hematuria, who was diagnosed with nested variant of urothelial carcinoma with infiltration of the lamina propria. Despite transurethral resection of the tumor and subsequent systemic treatment with platinum-based chemotherapy, the patient experienced rapid disease progression, which was characterized by pelvic and mediastinal lymph node infiltration, pulmonary lymphangitic dissemination, bilateral hydronephrosis, and thrombosis of the right internal jugular vein, as well as the left common iliac, external iliac, and femoral veins.
Conclusions: This report documents a case of muscle invader nested variant of urothelial carcinoma, whose evolution was complicated by pulmonary carcinomatous lymphangitis, an extremely rare manifestation. Early recognition of this variant is essential to guide the diagnostic and therapeutic approach in patients with high-risk histological variants.
References
1. International Agency for Research on Cancer. Estimated number of new cases in 2020, worldwide, both sexes, all ages. Lyon: IARC; 2020.
2. Taghizadeh Kermani A, Kalantari MR, Pishevar Feizabad Z, et al. A nested variant of urothelial carcinoma of the urethra and urinary bladder: A case report and review of literature. Clin Case Rep. 2023;11(6):e7360. doi: 10.1002/ccr3.7360
3. Van der Heijden AG, Bruins HM, Carrion A, et al. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines. Eur Urol. 2025;87(5):582-600. doi: 10.1016/j.eururo.2025.02.019
4. AK AK, Mantri SN. Lymphangitic carcinomatosis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
5. Stern JB. Unusual benign bladder tumor of Brunn nest origin. Urology. 1979;14(3):288-9. doi: 10.1016/0090-4295(79)90505-3
6. Moch H, Cubilla AL, Humphrey PA, et al. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. Eur Urol. 2016;70(1):93-105. doi: 10.1016/j.eururo.2016.02.029
7. Sugimoto H, Sugimoto K, Inoue H, et al. Pulmonary lymphangitic carcinomatosis secondary to ureteral cancer. Respir Med Case Rep. 2021;32:101348. doi:10.1016/j.rmcr.2021.101348
8. Jindal T, Dhanalakshmi M, Pawar P. Pulmonary lymphangitis carcinomatosa in a patient with carcinoma of urinary bladder. Indian J Urol. 2020;36(3):216-8. doi: 10.4103/iju.IJU_148_20
9. Saini T, Bekal S, Liman AD. Lymphangitic carcinomatosis of possible urothelial origin. Cureus. 2023;15(3):e36030. doi: 10.7759/cureus.36030
10. Hendin AS, Deveney CW. Postmortem demonstration of abnormal deep pulmonary lymphatic pathways in lymphangitic carcinomatosis. Cancer. 1974;33(6):1558-63. doi:10.1002/1097-0142(197406)33:6<1558::AID-CNCR2820330613>3.0.CO;2-I
11. Guddati AK, Marak CP. Pulmonary lymphangitic carcinomatosis due to renal cell carcinoma. Case Rep Oncol. 2012;5(2):246-52. doi: 10.1159/000339126
Article Sidebar
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors retain their copyright and grant the Revista Médica del IMSS the right of first publication. Articles are distributed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows sharing as long as the author and the original source are properly credited.